Literature DB >> 6340253

Treatment of ischaemic stroke with prostacyclin.

R J Gryglewski, S Nowak, E Kostka-Trabka, J Kusmiderski, A Dembinska-Kiec, K Bieron, M Basista, B Blaszczyk.   

Abstract

Ten patients with ischaemic stroke were treated with prostacyclin (2.5-5.0 ng/kg/min i.v. in 6 h courses 4-10 times during 1-2.5 days). In all patients a dramatic regression of hemiplegia, or hemiparesis, or aphasia occurred in the first few hours of prostacyclin infusion. Four to eight weeks later 6 patients left the clinic without neurological deficit; 3 patients had minor residual hemiparesis in upper limbs. In one patient, the occlusion of the contralateral carotid artery led to his death. It is considered that an antagonism may exist between endogenous cerebral prostanoids and prostacyclin and may have been responsible for the beneficial effects of prostacyclin therapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6340253     DOI: 10.1161/01.str.14.2.197

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  13 in total

1.  Prostacyclin receptor deletion aggravates hippocampal neuronal loss after bilateral common carotid artery occlusion in mouse.

Authors:  G Wei; K K Kibler; R C Koehler; T Maruyama; S Narumiya; S Doré
Journal:  Neuroscience       Date:  2008-08-20       Impact factor: 3.590

Review 2.  Drug treatment of stroke. Current status and future prospects.

Authors:  C A Sila; A J Furlan
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

3.  Controversies in the medical management of stroke.

Authors: 
Journal:  West J Med       Date:  1985-01

4.  Prostacyclin--powerful, yes: but is it useful?

Authors:  J R Mitchell
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-17

5.  Stable prostacyclin improves postischaemic microcirculatory changes in hypertensive rats.

Authors:  K Shima; H Umezawa; H Chigasaki; S Okuyama; H Araki
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

6.  Prostacyclin infusion may prevent secondary damage in pericontusional brain tissue.

Authors:  Peter Reinstrup; Carl-Henrik Nordström
Journal:  Neurocrit Care       Date:  2011-06       Impact factor: 3.210

Review 7.  Prostaglandins, thromboxanes and leukotrienes in clinical medicine.

Authors:  R D Zipser; G Laffi
Journal:  West J Med       Date:  1985-10

Review 8.  Prostacyclin and analogues for acute ischaemic stroke.

Authors:  P M W Bath
Journal:  Cochrane Database Syst Rev       Date:  2004

9.  International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions.

Authors:  Xavier Norel; Yukihiko Sugimoto; Gulsev Ozen; Heba Abdelazeem; Yasmine Amgoud; Amel Bouhadoun; Wesam Bassiouni; Marie Goepp; Salma Mani; Hasanga D Manikpurage; Amira Senbel; Dan Longrois; Akos Heinemann; Chengcan Yao; Lucie H Clapp
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

10.  Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation.

Authors:  T F Choudhri; B L Hoh; H G Zerwes; C J Prestigiacomo; S C Kim; E S Connolly; G Kottirsch; D J Pinsky
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.